Metagenics will appeal Bone Builder ruling by FTC judge.
This article was originally published in The Tan Sheet
Executive Summary
METAGENICS BONE BUILDER CLAIMS: COMPANY WILL APPEAL FTC RULING that the firm's data fail to uphold bone restoration claims, bone ailment-related pain reduction claims or superiority claims for its Bone Builder calcium supplement. The ruling, handed down by Federal Trade Commission Administrative Law Judge Lewis Parker Oct. 11, was announced by Clemente, Calif.-based Metagenics on Oct. 29.